SC 13D/A

MARK WEINREB SCHEDULE 13D AMENDMENT NO. 2

Company: BioRestorative Therapies, Inc.
Filed: July 7, 2017
Accession Number: 0001021771-17-000073

View Document ↗ View on SEC.gov ↗